XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in XBiotech Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +7 vs. Q4 2023
- Shares held
- 3.99M
- +548.0K (+15.9%) vs. Q4 2023
- Total value
- $32.5M
- +$18.7M (+135.5%) vs. Q4 2023
- New holders
- 10
- 16 more added
- Sold out
- 3
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 927,368 | $7.54M | 0.01% | +131,642+16.5% | Added |
| Vanguard Group Inc | 895,315 | $7.28M | 0.00% | +13,804+1.6% | Added |
| BlackRock Inc. | 306,624 | $2.49M | 0.00% | +28,465+10.2% | Added |
| Credit Suisse AG | 248,270 | $2.02M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 195,204 | $1.59M | 0.00% | +2,616+1.4% | Added |
| Susquehanna International Group, LLP | 169,812 | $1.38M | 0.00% | +132,366+353.5% | Added |
| Bridgeway Capital Management, LLC | 149,318 | $1.21M | 0.02% | +4,725+3.3% | Added |
| Morgan Stanley | 116,327 | $945.7K | 0.00% | +5,810+5.3% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 77,413 | $629.4K | 0.00% | +13,468+21.1% | Added |
| Northern Trust Corp | 75,389 | $612.9K | 0.00% | −3,638−4.6% | Reduced |
| Dimensional Fund Advisors LP | 72,475 | $589.2K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 67,662 | $550.1K | 0.00% | +11,185+19.8% | Added |
| Empowered Funds, LLC | 64,277 | $522.6K | 0.01% | +4,725+7.9% | Added |
| Goldman Sachs Group Inc | 62,161 | $505.4K | 0.00% | +62,161 | New |
| State Street Corp | 56,526 | $459.6K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 54,822 | $445.7K | 0.00% | +38,495+235.8% | Added |
| Marshall Wace, LLP | 54,679 | $444.5K | 0.00% | +54,679 | New |
| Bank of New York Mellon Corp | 48,451 | $393.9K | 0.00% | −7,242−13.0% | Reduced |
| Citigroup Inc | 36,752 | $298.8K | 0.00% | +22,013+149.4% | Added |
| HRT Financial LP | 33,593 | $273.0K | 0.00% | +33,593 | New |
| National Bank of Canada | 33,000 | $271.6K | 0.00% | +8,653+35.5% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 25,954 | $211.0K | 0.05% | +25,954 | New |
| Balyasny Asset Management LLC | 21,865 | $177.8K | 0.00% | +21,865 | New |
| Brevan Howard Capital Management LP | 20,578 | $167.3K | 0.02% | +20,578 | New |
| FMR LLC | 19,966 | $162.3K | 0.00% | −74−0.4% | Reduced |
| Two Sigma Advisers, LP | 18,433 | $149.9K | 0.00% | −5,567−23.2% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 18,043 | $146.7K | 0.01% | +18,043 | New |
| Price T Rowe Associates Inc | 17,600 | $144.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 16,177 | $132.0K | 0.00% | +16,177 | New |
| Thomasville National Bank | 13,350 | $108.5K | 0.01% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12,522 | $101.8K | 0.00% | +1,200+10.6% | Added |
| Synovus Financial Corp | 11,796 | $95.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 10,707 | $87.0K | 0.00% | −14,733−57.9% | Reduced |
| Charles Schwab Investment Management Inc | 10,477 | $85.2K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,690 | $70.7K | 0.00% | −4,668−34.9% | Reduced |
| UBS Group AG | 7,344 | $59.7K | 0.00% | −2,105−22.3% | Reduced |
| Citadel Advisors LLC | 7,042 | $57.3K | 0.00% | −5,232−42.6% | Reduced |
| Cubist Systematic Strategies, LLC | 5,254 | $42.7K | 0.00% | +5,254 | New |
| Tower Research Capital LLC (TRC) | 1,117 | $9.08K | 0.00% | +1,065+2,048.1% | Added |
| McIlrath & Eck, LLC | 753 | $6.12K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 753 | $6.12K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 155 | $1.26K | 0.00% | +3+2.0% | Added |
| Simplex Trading, LLC | 228 | $1.00K | 0.00% | −398−63.6% | Reduced |
| Royal Bank of Canada | 99 | $1.00K | 0.00% | −189−65.6% | Reduced |
| JPMorgan Chase & Co | 38 | $309 | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 576 | $5 | 0.00% | +576 | New |
| Man Group plc | 0 | $0 | 0.00% | −58,355−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,922−100.0% | Sold out |
| LGT Fund Management Co Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |